Endo International | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
AbbVie USD 3.32B 2.71B 2024-12
Amarin USD 531.38M 20.5M 2024-09
ANI Pharmaceuticals USD 418.62M 14.94M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Hikma Pharmaceutical USD 2.32B 35M 2024-12
Ligand Pharmaceuticals USD 795.53M 34.9M 2025-03
Merck USD 48.34B 2.02B 2025-03
Novartis USD 44.05B 605M 2024-12
Pacira USD 798.54M 20.19M 2025-03
Perrigo USD 4.36B 44.6M 2025-03
Pfizer USD 90.34B 2.14B 2025-03
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12
Takeda JPY 6.94T 483.19B 2025-03
Teva Pharmaceutical Industries USD 6.26B 542M 2025-03
Xeris Pharmaceuticals USD -29615000 1.29M 2024-12
Zoetis USD 4.66B 115M 2025-03



Endo International Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jun 2025.